Both in Pharmaceuticals
Roivant Sciences vs Jazz Pharmaceuticals
Over the past year ROIV returned +101.6% and JAZZ returned +48.5%; their daily moves had a correlation of 0.20.
ROIV +101.6% JAZZ +48.5%Growth of $1, one year, split-adjusted
| Metric | ROIV | JAZZ |
|---|---|---|
| Price | $37.11 | $205.06 |
| Market cap | $26.81B | $13.31B |
| Today | +1.56% | −0.83% |
| 1 month | +1.7% | −11.7% |
| 6 months | +34.8% | +2.6% |
| Year to date | +71.0% | +20.6% |
| 1 year | +97.3% | +47.2% |
| Revenue growth (YoY) | −33.5% | +15.5% |
| Gross margin | 100.0% | 90.4% |
| Net margin | −13164.8% | 16.0% |
| P/E (TTM) | — | 14.1× |
| Price / sales | 3,558.9× | 2.9× |
| Net cash | $3.84B | -$2.15B |
| Dividend yield | — | — |
| Volatility (60d) | 49.1% | 26.5% |
| Short % of float | 8.0% | 9.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).